等待开盘 07-25 09:30:00 美东时间
+2.550
+0.59%
<p>Hubbell Incorporated will release its second quarter 2025 financial results before the market opens on July 29, 2025. The company will host an Analysts' Conference Call at 10:00 AM ET to discuss the results. The press release and conference call materials will be available on Hubbell's website under the "Press Releases" and "Events/Presentations" sections. Hubbell, a leading manufacturer of utility and electrical solutions, reported 2024 reven...
07-10 20:40
Barclays analyst Julian Mitchell maintains Hubbell (NYSE:HUBB) with a Equal-Weight and raises the price target from $414 to $420.
07-09 23:35
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
Wells Fargo analyst Joseph O'Dea maintains Hubbell (NYSE:HUBB) with a Equal-Weight and raises the price target from $363 to $420.
07-01 21:55
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Metsera(MTSR)"买入"评级,目标价从56美元升至62美元</p> <p>• 摩根大通:维持Avidity Biosciences(RNA)"超配"评级,目标价从57美元升至59美元</
06-11 09:43
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139116149842006017.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持PolyPid(PYPD)"买入"评级,目标价从11美元升至13美元</p> <p>• HC Wainwright & Co.:维持Vertical Aerosp
06-10 09:45
Throughout the last three months, 4 analysts have evaluated Hubbell (NYSE:HUBB)...
06-10 05:00
Barclays analyst Julian Mitchell maintains Hubbell (NYSE:HUBB) with a Equal-Weight and raises the price target from $400 to $414.
06-10 00:58
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities:维持Mersana Therapeutics(MRSN)"买入"评级,目标价从9美元升至10美元</p> <p>• Guggenheim:维持Cabaletta Bio(CABA)"买入
05-17 08:44
JP Morgan analyst Stephen Tusa maintains Hubbell (NYSE:HUBB) with a Neutral and raises the price target from $352 to $417.
05-17 04:45